EDGE
Get a demo
Log In

Augmedics

Extended Reality
Product stageSegments
Early
?
AR/VR platforms
?

Augmedics is a provider of surgical guidance solutions that leverage AR. Its first product, the xvision-spine (XVS) system, which was cleared by the US Food and Drug Administration (FDA) in December 2019, allows surgeons to visualize the 3D spinal anatomy by allowing them to see through skin and tissue (like X-Ray vision) while performing complex spine procedures. 

The system comes with a near-eye-display headset in addition to all elements of a traditional navigation system. It can track and position surgical tools in real time and project the navigation onto the transparent AR display without attracting the surgeon’s attention to a remote screen. In March 2023 Augmedics announced the launch of a new set of FDA-cleared features for its xvision platform, following its 3,000th patent milestone.

In August 2023, Augmedics acquired the digital health assets of Surgalign and Holo Surgical for USD 0.9 million in cash. The company integrated these offerings with its own AR-based and AI-based solutions, including its FDA-cleared xvision platform.

The company claims the system also provides better visualization, control, and accuracy. The system, which the company claims is the only FDA-approved augmented reality surgical image guidance system, was commercially made available in the US in the second half of 2020.

The company generates revenue through outright sales of the system, which costs around USD 180,000, to surgical centers. 

Key customers and partnerships

In January 2024, the company had noted that its xvision Spine System was used in the treatment of ~5,000 US patients since the system's inception.

Funding and financials

In June 2023, Augmedics raised USD 82.5 million in a Series D funding round led by CPMG. The funding was to be used to continue expanding Augmedics' US commercial footprint and enable mass-scale adoption of its proprietary xvision technology. 


Extended Reality

Extended Reality

Key stats
Featured companies
239
Total funding (USD)
13.6 Bn
Total addressable market (USD)
100.4 Bn
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

XR and MEP (Q3 2023): Product improvements continue despite stagnant funding
Digital Health (Q2 2023): Funding flow steady; first AI-drug enters Phase II clinical trials
XR and MEP (Q2 2023): Apple's Vision Pro fuels XR's cautious comeback as metaverse plummets
XR and MEP (Q1 2023): From virtual promise to metaverse hesitation

Recent Updates

M&A
Aug 1, 2023
Augmedics acquires assets of bankrupt Surgalign for USD 0.9 million
Extended Reality
Funding
Jun 27, 2023
MedTech firm Augmedics raises USD 82.5 million in Series D funding
Extended Reality
Product updates
Mar 8, 2023
VR surgical guidance platform Augmedics announces launch of new FDA-cleared features
Extended Reality

Company Brief


HQ location:
21 S. Evergreen Ave Suite 230 Arlington Heights, IL USA Arlington Heights IL USA
Founded year:
2014
Employees:
101-250
Total Funding:
USD 143.6 million
Last Funding
USD 82.5 million, Jun 2023

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.